Objectives Breast Cancer is a stressful event. Several breast cancer patients may suffer from clinically relevant symptoms of depression and/or anxiety. Indeed,resilience represents an important psychosocial factor. We aim to report the resilience of breast cancer women and its association with depression and anxiety.

Methods It is a cross-sectional descriptive study conducted over a third-month period, from January 2nd, 2020 to March 30th, 2020 at Salah Azaiez Institute including 61 breast cancer patients.

Results The median age was 55.7 years. Forty-six percent were housewives. The illiteracy rate was 34.4%. The average duration of marriage was 27.8 years.Co-morbidities were found in 36.1% of patients. The average time after treatment was 60.8 months.57.4% of patients were classified as stage II. Radical surgery was conducted in 70.5% of patients. Chemotherapyand Hormone therapy were administered in 90.2% and 83.6% of cases, respectively. The average score of resilience (RS-14) was de 76.6. The average scores of anxiety and depression were10.5 and 8.6, respectively.Clinically relevant symptoms of anxiety and depression were reported with52.5% and 29.5% of patients, respectively. Correlation analysis showed that the RS-14 and anxiety and depression of the HAD scale were in negative correlation (r= -0.419, p<0.001) and (r= -0.606, p<0.001), respectively. Predictor factors of resilience were co-morbidities and not receiving hormone therapy.

Conclusions Resilience represents a protective psychosocial factor against anxiety and depression among breast cancer patients. A multidisciplinary healthcare team is crucial for patient psychosocial care throughout the cancer continuum allowing to promote resilience and leading to enhance the quality of life.